ArticlemedRxiv : the preprint server for health sciences2025
Advancing the prediction and understanding of placebo responses in chronic back pain using large language models.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
9 authors.
Funding
Abstract
Placebo analgesia in chronic pain is a widely studied clinical phenomenon, where expectations about the effectiveness of a treatment can result in substantial pain relief when using an inert treatment agent. While placebos offer an opportunity for non-pharmacological treatment in chronic pain, not everyone demonstrates an analgesic response. Prior research has identified biopsychosocial factors that determine the likelihood of an individual to respond to a placebo, yet generalizability and ecological validity in those studies have been limited due to the inability to account for dynamic personal and treatment effects-which are well-known to play a role. Here, we assessed the potential of using fine-tuned large language models (LLMs) to predict placebo responders in chronic low-back pain using contextual features extracted from patient interviews, as they speak about their lifestyle, pain, and treatment history. We re-analyzed data from two clinical trials where individuals performed open-ended interviews and used these to develop a predictive model of placebo response. Our findings demonstrate that semantic features extracted with LLMs accurately predicted placebo responders, achieving a classification accuracy of 74% in unseen data, and validating with 70% accuracy in an independent cohort. Further, LLMs eliminated the need for pre-selecting search terms or to use dictionary approaches, enabling a fully data-driven approach. This LLM method further provided interpretable insights into psychosocial factors underlying placebo responses, highlighting nuanced linguistic patterns linked to responder status, which tap into semantic dimensions such as "anxiety," "resignation," and "hope." These findings expand on prior research by integrating state-of-art NLP techniques to address limitations in interpretability and context sensitivity of standard methods like bag-of-words and dictionary-based approaches. This method highlights the role of language models to link language and psychological states, paving the way for a deeper yet quantitative exploration of biopsychosocial phenomena, and to understand how they relate to treatment outcomes, including placebo.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.